Literature DB >> 3035210

B-lymphoma induction by reticuloendotheliosis virus: characterization of a mutated chicken syncytial virus provirus involved in c-myc activation.

R A Swift, C Boerkoel, A Ridgway, D J Fujita, J B Dodgson, H J Kung.   

Abstract

Nondefective reticuloendotheliosis virus induces chicken bursal lymphoma in a manner similar to that of avian leukosis virus. The provirus integrates in the c-myc locus and uses a promoter insertion mechanism to activate c-myc expression. We cloned a provirus involved in c-myc activation from a B lymphoma. Detailed structural characterization of this clone, including sequence determination, revealed proviral insertion at 512 base pairs preceding the second c-myc exon. The provirus has a deletion of 80% of the viral genes but retains two intact long terminal repeats (LTRs). A segment of the viral env sequence is present in an inverted orientation. Elevated expression of c-myc, apparently directed by the 3' LTR, was detected. However, despite the presence of an intact 5' LTR, no viral transcripts were detected. Thus, the internal proviral rearrangement can affect 5' LTR transcription or stability of the message or both. This finding is in consonance with the view that proviral deletion plays an important role in the induction of bursal lymphomas by nonacute retroviruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035210      PMCID: PMC254228          DOI: 10.1128/JVI.61.7.2084-2090.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

2.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

3.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IV. The F sequences in F14.

Authors:  E Otsubo; R C Deonier; H J Lee; N Davidson
Journal:  J Mol Biol       Date:  1974-11-15       Impact factor: 5.469

4.  Cultivation of a filterable agent associated with Marek's disease.

Authors:  M K Cook
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

5.  Electron microscope heteroduplex study of the heterogeneity of Mu phage and prophage DNA.

Authors:  M T Hsu; N Davidson
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

6.  Sequence of retrovirus provirus resembles that of bacterial transposable elements.

Authors:  K Shimotohno; S Mizutani; H M Temin
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Lymphomas resembling lymphoid leukosis in chickens inoculated with reticuloendotheliosis virus.

Authors:  R L Witter; L B Crittenden
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  12 in total

1.  Transcriptionally active genome regions are preferred targets for retrovirus integration.

Authors:  U Scherdin; K Rhodes; M Breindl
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

2.  Replication-defective vectors of reticuloendotheliosis virus transduce exogenous genes into somatic stem cells of the unincubated chicken embryo.

Authors:  R A Bosselman; R Y Hsu; T Boggs; S Hu; J Bruszewski; S Ou; L Souza; L Kozar; F Martin; M Nicolson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 3.  Provirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenes.

Authors:  A Berns
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Localization and footprinting of an enhancer within the avian sarcoma virus gag gene.

Authors:  K Carlberg; T A Ryden; K Beemon
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Functional interaction between transcriptional elements in the long terminal repeat of reticuloendotheliosis virus: cooperative DNA binding of promoter- and enhancer-specific factors.

Authors:  A Hirano; T Wong
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  Avian proto-myc genes promoted by defective or nondefective retroviruses are single-hit transforming genes in primary cells.

Authors:  R P Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone.

Authors:  D Jones; P Brunovskis; R Witter; H J Kung
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.

Authors:  C F Boerkoel; H J Kung
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences.

Authors:  D Jones; R Isfort; R Witter; R Kost; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Retrovirus insertion into herpesvirus in vitro and in vivo.

Authors:  R Isfort; D Jones; R Kost; R Witter; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.